Hippocratic AI Secures $141M Funding to Revolutionize Healthcare with AI Agents

Hippocratic AI Secures Massive Funding for Healthcare AI Agents

Hippocratic AI, a healthcare-focused artificial intelligence startup, has raised $141 million in a Series B funding round, bringing its total funding to over $278 million and valuation to $1.64 billion 1

1

2

2

. The round was led by Kleiner Perkins, with participation from A16z, General Catalyst, Premji, NVIDIA, SV Angel, Universal Health Services, and WellSpan Health 1

1

.

Innovative Approach to Healthcare Staffing

The startup, co-founded by CEO Munjal Shah and a team of healthcare professionals and AI researchers, aims to address the global shortage of healthcare workers by developing AI agents capable of performing non-diagnostic, patient-facing tasks 1

1

2

2

. These AI agents are designed to support various aspects of patient care, including chronic care management, medication checks, and post-discharge follow-ups 1

1

.

Launch of Healthcare AI Agent App Store

Coinciding with the funding announcement, Hippocratic AI has launched its Healthcare AI Agent App Store 1

1

. This platform allows clinicians to participate in the design of AI agents tailored to their areas of expertise. The company claims that clinicians can create an AI agent prototype in less than 30 minutes and develop a testable version in 3-4 hours 1

1

.

Collaboration with Healthcare Professionals

Hippocratic AI emphasizes the importance of clinician involvement in developing safe and effective AI agents. The startup works with licensed clinicians to create specialized AI agents for various medical specialties 1

1

. Notable contributors include:

• Dr. Vanessa Dorismond: Created an AI agent focused on cervical cancer check-ins and patient education 1

  1

• Kacie Spencer: Developed an AI agent for patient education on proper child car seat installation 1

  1

• Kristina Dulaney: Contributed to an AI agent addressing maternal mental health challenges 1

  1

Rigorous Safety Measures

To ensure the safety and efficacy of its AI agents, Hippocratic AI implements a comprehensive evaluation process. This includes initial testing, extensive evaluations, and safety assessments conducted by a network of over 6,000 nurses and 300 doctors 1

1

.

Rapid Growth and Market Traction

Since its previous funding round nine months ago, Hippocratic AI has made significant progress. The company has:

1. Received its first U.S. patents
2. Fully evaluated and verified the safety of its initial AI healthcare agents
3. Signed contracts with 23 health systems, payors, and pharma clients 1

   1

   2

   2

Future Expansion Plans

With the new capital, Hippocratic AI plans to expand its product offerings into more markets, including international expansion 2

2

. The company's focus on creating AI agents for tasks such as pre-operating procedures, remote patient monitoring, and appointment preparation positions it uniquely in the healthcare AI landscape 2

2

.

As the healthcare industry continues to grapple with staffing shortages, Hippocratic AI's innovative approach to leveraging AI agents for patient care tasks could potentially transform the delivery of healthcare services and improve patient outcomes.